학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 8건 | 목록
1~20
Academic Journal
van den Bent MJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address: m.vandenbent@erasmusmc.nl.; Ghisai SA; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Wick W; Neurological Clinic and National Center for Tumor Diseases, Heidelberg University Hospital, Germany.; Sanson M; Sorbonne University, Inserm, CNRS, UMR S 1127, Paris Brain Institute (ICM) AP-HP, Paris, France; Neuro-Oncology Department, Pitié-Salpêtrière Hospital, Paris, France.; Brandes AA; Medical Oncology Department, AUSL-IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy.; Clement PM; Department of Oncology, KU Leuven and Department of General Medical Oncology, UZ Leuven, Leuven Cancer Institute, Leuven, Belgium.; Erridge SC; Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburgh, UK.; Vogelbaum MA; Neuro-Oncology Department, Moffitt Cancer Center, Tampa, FL, USA.; Nowak AK; Medical School, University of Western Australia, Perth, WA, Australia; Cooperative Trials Group for Neuro-Oncology, University of Sydney, Sydney, NSW, Australia.; Baurain JF; Medical Oncology Department, King Albert II Cancer Institute, Saint-Luc University Hospitals, Catholic University of Louvain, Brussels, Belgium.; Mason WP; Department of Neurology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.; Wheeler H; Northern Sydney Cancer Centre, University of Sydney, Sydney, NSW, Australia.; Tabouret E; GlioME Team, Institute of Neurophysiopathology, CNRS, Aix-Marseille University, Marseille, France; Department of Neuro-Oncology, APHM, CHU Timone, Marseille, France; PE'TRANSLA', Preclinical and Translational Research in Neuro-Oncology (PETRA), Aix-Marseille University, Marseille, France.; Gill S; Department of Medical Oncology, Alfred Hospital, Melbourne, VIC, Australia.; Griffin M; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Taal W; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Rudà R; Department of Neuro-Oncology, City of Health and Science Hospital and University of Turin, Turin, Italy.; Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; McBain C; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Reijneveld JC; Brain Tumor Center Amsterdam and Department of Neurology, Amsterdam UMC, Amsterdam, Netherlands.; Enting RH; Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; Tran S; Radiation Oncology Department, Geneva University Hospitals, Geneva, Switzerland.; Lesimple T; Department of Clinical Oncology, Eugène Marquis Comprehensive Cancer Centre, Rennes, France.; Kocher M; Department for Stereotaxy and Functional Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Gijtenbeek A; Department of Neurology, Radboud University Medical Centre, Nijmegen, Netherlands.; Lim E; Plymouth Oncology Centre, Derriford Hospital, Plymouth Hospitals NHS Trust, Plymouth, UK.; Herrlinger U; Department of Neurooncology, Center for Neurology, University of Bonn Medical Center, Bonn, Germany.; Hau P; Wilhelm Sander Neuro-Oncology Unit and Department of Neurology, University Hospital Regensburg, Regensburg, Germany.; Dhermain F; Radiotherapy Department, Gustave Roussy University Hospital, Villejuif, France.; Aldape K; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Kros JM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Wesseling P; Department of Pathology, Amsterdam UMC/VUMC, Amsterdam, Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Hoogstrate Y; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Nuyens S; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Golfinopoulos V; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Tesileanu CMS; Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA.; Gorlia T; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; French P; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Baumert BG; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center and GROW School for Oncology, Maastricht, Netherlands; Institute of Radiation-Oncology, Cantonal Hospital Graubunden, Chur, Switzerland.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
van Hijfte L; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. l.vanhijfte@erasmusmc.nl.; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. l.vanhijfte@erasmusmc.nl.; Geurts M; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; de Heer I; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Ghisai SA; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Balcioglu HE; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Hoogstrate Y; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Vallentgoed WR; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Head R; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Luning R; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; van den Bosch T; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.; Westerman B; Department of Neurosurgery, Amsterdam UMC/VUMC, Amsterdam, The Netherlands.; Wesseling P; Department of Pathology, Amsterdam UMC/VUMC and Brain Tumour Center, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Joyce JA; Department of Oncology, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland.; Agora Cancer Center Lausanne and Swiss Cancer Center Léman, Lausanne, Switzerland.; French P; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. p.french@erasmusmc.nl.; Debets R; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. j.debets@erasmusmc.nl.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Ghisai SA; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; van Hijfte L; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Tumour Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Vallentgoed WR; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Tesileanu CMS; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; de Heer I; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Kros JM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Sanson M; ICM Institute for Brain and Spinal Cords, Sorbonne University, Paris, France.; Gorlia T; EORTC Headquarters, Brussels, Belgium.; Wick W; Neurology Department, University Clinic Heidelberg, Heidelberg University & German Center, Heidelberg, Germany.; Vogelbaum MA; Neuro-Oncology Department, Moffitt Cancer Center, Tampa, FL, USA.; Brandes AA; Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Franceschi E; Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Clement PM; Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; Nowak AK; Medical School, The University of Western Australia, Crawley, WA, Australia.; Golfinopoulos V; EORTC Headquarters, Brussels, Belgium.; van den Bent MJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; French PJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. p.french@erasmusmc.nl.; Hoogstrate Y; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
Academic Journal
Ghisai SA; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Barin N; Department of Precision and Microsystems Engineering, Delft University of Technology, Delft, The Netherlands.; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; van Hijfte L; Department of Tumor Immunology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Verhagen K; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; de Wit M; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; van den Bent MJ; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Hoogstrate Y; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; French PJ; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Academic Journal
Hoogstrate Y; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Cancer Computational Biology Center, Erasmus MC, Rotterdam, The Netherlands.; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.; Ghisai SA; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; de Wit M; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; de Heer I; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Draaisma K; Department of Neurosurgery, UMC Utrecht, Utrecht, The Netherlands.; van Riet J; Cancer Computational Biology Center, Erasmus MC, Rotterdam, The Netherlands.; van de Werken HJG; Cancer Computational Biology Center, Erasmus MC, Rotterdam, The Netherlands.; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.; Bours V; Department of Human Genetics, Université de Liège, Liège, Belgium.; Buter J; Department of Oncology, VU University Medical Center, Amsterdam, The Netherlands.; Vanden Bempt I; Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium.; Eoli M; Unit of Molecular Neuro-Oncology, Besta-IRCCS, Milan, Italy.; Franceschi E; IRCCS Istituto Scienze Neurologiche di Bologna, Nervous System Medical Oncology Department, Bologna, Italy.; Frenel JS; Institut de Cancérologie de l'Ouest, Nantes, France.; Gorlia T; EORTC Headquarters, Brussels, Belgium.; Hanse MC; Department of Neurology, Catharina Hospital, Eindhoven, The Netherlands.; Hoeben A; Department of Medical Oncology, Maastricht UMC+, Maastricht, The Netherlands.; Kerkhof M; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.; Kros JM; Department of Medical Oncology, Erasmus MC, Rotterdam, The Netherlands.; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.; Leenstra S; Department of Neurosurgery, Erasmus MC, Rotterdam, The Netherlands.; Lombardi G; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Lukacova S; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Robe PA; Department of Neurosurgery, UMC Utrecht, Utrecht, The Netherlands.; Sepulveda JM; Hospital Universitario 12 de Octubre, Madrid, Spain.; Taal W; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Taphoorn M; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.; Vernhout RM; Department of Radiotherapy, Erasmus MC, Rotterdam, The Netherlands.; Walenkamp AME; Department of Medical Oncology, UMC Groningen, Groningen, The Netherlands.; Watts C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Weller M; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.; de Vos FYF; Department of Medical Oncology, UMC Utrecht, Utrecht, The Netherlands.; Jenster GW; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.; van den Bent M; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; French PJ; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Academic Journal
Ghisai SA; van Hijfte L; Vallentgoed WR; Tesileanu CMS; de Heer I; Kros JM; Sanson M; Gorlia T; Wick W; Vogelbaum MA; Brandes AA; Franceschi E; Clement PM; Nowak AK; Golfinopoulos V; van den Bent MJ; French PJ; Hoogstrate Y
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Hoogstrate Y; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands. Electronic address: y.hoogstrate@erasmusmc.nl.; Draaisma K; Department of Neurosurgery, UMC Utrecht, 3584CX Utrecht, the Netherlands.; Ghisai SA; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; van Hijfte L; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; Barin N; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Department of Precision and Microsystems Engineering, Delft University of Technology, 2628CD Delft, the Netherlands.; de Heer I; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; Coppieters W; Genomics Platform, GIGA Institute, Université de Liège, 4000 Liège, Belgium.; van den Bosch TPP; Department of Pathology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; Bolleboom A; Deparment of Neuroscience, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Department of Neurosurgery, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; Gao Z; Deparment of Neuroscience, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; Vincent AJPE; Department of Neurosurgery, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; Karim L; Genomics Platform, GIGA Institute, Université de Liège, 4000 Liège, Belgium.; Deckers M; Genomics Platform, GIGA Institute, Université de Liège, 4000 Liège, Belgium.; Taphoorn MJB; Department of Neurology, Haaglanden Medical Center, 2512VA The Hague, the Netherlands; Department of Neurology, Leiden University Medical Center, 2333ZA Leiden, the Netherlands.; Kerkhof M; Department of Neurology, Haaglanden Medical Center, 2512VA The Hague, the Netherlands.; Weyerbrock A; Department of Neurosurgery, Medical Center - University of Freiburg, 79106 Freiburg, Germany; Faculty of Medicine, University of Freiburg, 79085 Freiburg, Germany.; Sanson M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.; Hoeben A; Department of Internal Medicine, Division of Medical Oncology, GROW, Maastricht University Medical Center, 6229ER Maastricht, the Netherlands.; Lukacova S; Department of Oncology, Aarhus University Hospital, 8200 Aarhus, Denmark.; Lombardi G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.; Leenstra S; Department of Neurosurgery, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; Hanse M; Department of Neurology, Catharina Hospital, 5623EJ Eindhoven, the Netherlands.; Fleischeuer REM; Department of Pathology, Elisabeth-TweeSteden Hospital, 5042AD Tilburg, the Netherlands.; Watts C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2SY Birmingham, UK.; Angelopoulos N; Systems Immunity Research Institute, Medical School, Cardiff University, CF14 4XN Cardiff, UK.; Gorlia T; EORTC Headquarters, 1200 Brussels, Belgium.; Golfinopoulos V; EORTC Headquarters, 1200 Brussels, Belgium.; Bours V; Université de Liège, Department of Human Genetics, 4000 Liège, Belgium.; van den Bent MJ; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.; Robe PA; Department of Neurosurgery, UMC Utrecht, 3584CX Utrecht, the Netherlands; Université de Liège, Department of Human Genetics, 4000 Liège, Belgium.; French PJ; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands. Electronic address: p.french@erasmusmc.nl.
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Academic Journal
te Stroet MA; Department of Orthopaedics, Radboud University Medical Center, Nijmegen, The Netherlands, Martijn.teStroet@radboudumc.nl.; Ghisai SA; Keurentjes JC; Rijnen WH; Gardeniers JW; Van Kampen A; Schreurs BW
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7705431 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5195 (Electronic) Linking ISSN: 03412695 NLM ISO Abbreviation: Int Orthop Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Ghisai SA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어